NeuroOne Medical Technologies Corporation (NMTC) Operating cash flow 2016–2025
NeuroOne Medical Technologies Corporation (NMTC) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$2.8MFY2025 · since FY2016: -$21,106 → -$2.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$2.8M | +74.2% |
| FY2024 | -$11.0M | +14.5% |
| FY2023 | -$12.9M | -71.4% |
| FY2022 | -$7.5M | +12.6% |
| FY2021 | -$8.6M | -151.2% |
| FY2020 | -$3.4M | +36.5% |
| FY2019 | -$5.4M | — |
| FY2017 | -$2.1M | -9888.0% |
| FY2016 | -$21,106 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NMTC financial trends
NMTC RevenueNMTC Net incomeNMTC Net marginNMTC Gross profitNMTC Gross marginNMTC Operating incomeNMTC Operating marginNMTC Free cash flowNMTC Capital expendituresNMTC Return on equityNMTC Stock buybacksNMTC Dividends paidNMTC Total assetsNMTC Total liabilitiesNMTC Shareholders’ equityNMTC overview →